Markets are likely to end the week on an optimistic note amid strong global cues.

In the coming session, the zone of 11,530-11,500 is crucial to monitor as it is the confluence of upward sloping trendline support and 20-hour EMA level. Failure to hold above the 11,500 mark could be the first sign of weakness. Stocks in news: Yes Bank Ltd, Artson Engineering Ltd, Mahindra & Mahindra Ltd, GMR Infrastructure Ltd.

The consolidated net sales reported in Q1FY21 came in at Rs 1,937.5 crore, which declined by 40.64 per cent YoY from Rs 3,263.74 crore in Q1FY20. 

The consolidated net sales reported in Q1FY21 came in at Rs 955.40 crore, which declined by 12.63 per cent YoY from Rs 1,093.49 crore in Q1FY20.

Dr Reddy’s Laboratories Ltd announced the launch of Penicillamine capsules USP, 250 mg, a therapeutic equivalent generic version of Cuprimine (Penicillamine) capsules, 250 mg, approved by United States Food & Drug Administration (USFDA) on Thursday.

The shares of Blue Star Limited were trading as high as 15 per cent on Thursday after the company announced that it has won an electrical & mechanical works (E&M) order valued at Rs 149 crore.

Infosys, a global leader in the next-generation digital services & consulting, announced a five-year partnership with Genesys, a global leader in cloud customer experience and contact centre solutions. 

On the last expiry day of the month, Sensex and Nifty saw profit booking. Sensex managed to close at 39113.47 levels, up by 39.55 points or 0.10 per cent on Thursday. Nifty closed at 11559.25 levels, up by 9.65 points or 0.08 per cent.

Future Enterprises Ltd (FEL) announced that a meeting of the company’s board of directors is scheduled to be held for considering proposals of raising funds. Reacting to the announcement, the shares of various Future Group-owned companies soared high on Thursday.

Alembic has a total of 130 ANDA approvals, out of which, 113 are final approvals while 17 have tentative approvals from USFDA.